C17orf50

gene
On this page

Summary

C17orf50 (chromosome 17 open reading frame 50, HGNC:29581) is a protein-coding gene on chromosome 17q12, encoding Uncharacterized protein C17orf50 (Q8WW18).

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 13 total — 1 pathogenic
  • MANE Select transcript: NM_145272

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29581
Approved symbolC17orf50
Namechromosome 17 open reading frame 50
Location17q12
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000270806
Ensembl biotypeprotein_coding
Entrez146853

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000603305, ENST00000604830, ENST00000605587

RefSeq mRNA: 1 — MANE Select: NM_145272 NM_145272

CCDS: CCDS42298

Canonical transcript exons

ENST00000605587 — 3 exons

ExonStartEnd
ENSE000034629193576088735760954
ENSE000035258753576442635765079
ENSE000036021263576400735764325

Expression profiles

Bgee: expression breadth ubiquitous, 118 present calls, max score 95.14.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1705 / max 174.5699, expressed in 4 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
1603780.15204
1603770.01063
1603760.00422
1603790.00363

Top tissues by expression

234 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
left testisUBERON:000453395.14gold quality
right testisUBERON:000453494.96gold quality
spermCL:000001992.80gold quality
testisUBERON:000047391.61gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.54silver quality
adult organismUBERON:000702380.89gold quality
kidney epitheliumUBERON:000481963.63gold quality
sural nerveUBERON:001548862.03gold quality
biceps brachiiUBERON:000150761.03gold quality
deltoidUBERON:000147660.32gold quality
right uterine tubeUBERON:000130260.27gold quality
tibialis anteriorUBERON:000138560.13silver quality
nasal cavity epitheliumUBERON:000538459.07gold quality
corpus epididymisUBERON:000435958.84gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450258.65gold quality
cauda epididymisUBERON:000436058.46gold quality
bronchial epithelial cellCL:000232856.69gold quality
myocardiumUBERON:000234956.60gold quality
mucosa of paranasal sinusUBERON:000503056.50gold quality
nucleus accumbensUBERON:000188256.06gold quality
bronchusUBERON:000218555.94gold quality
nasal cavity mucosaUBERON:000182655.51gold quality
gingival epitheliumUBERON:000194955.38gold quality
caput epididymisUBERON:000435855.20gold quality
cartilage tissueUBERON:000241855.09gold quality
cardiac muscle of right atriumUBERON:000337954.98gold quality
gingivaUBERON:000182854.38gold quality
left ventricle myocardiumUBERON:000656654.23gold quality
jejunal mucosaUBERON:000039954.20gold quality
ileal mucosaUBERON:000033154.15silver quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.29

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

19 targeting C17orf50, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-29B-2-5P99.6768.981726
HSA-MIR-509399.6769.262291
HSA-MIR-569599.4167.481047
HSA-MIR-94099.3766.142064
HSA-MIR-6808-5P99.3166.232150
HSA-MIR-6893-5P99.3166.252119
HSA-MIR-329-5P99.2768.111597
HSA-MIR-578799.2267.862628
HSA-MIR-6848-5P98.8165.491126
HSA-MIR-6846-5P98.8165.861121
HSA-MIR-471098.6165.961048
HSA-MIR-425797.8668.051190
HSA-MIR-4640-5P97.4266.331543
HSA-MIR-4726-5P97.2465.671299
HSA-MIR-1212896.6766.981471
HSA-MIR-4790-3P96.6367.08806
HSA-MIR-1237-5P95.3862.21451
HSA-MIR-448895.3862.00443
HSA-MIR-4697-5P95.3861.72457

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculus1700020L24RikENSMUSG00000035085
rattus_norvegicusC10h17orf50ENSRNOG00000049757

Protein

Protein identifiers

Uncharacterized protein C17orf50Q8WW18 (reviewed: Q8WW18)

All UniProt accessions (3): Q8WW18, A0A075B7C2, A0A075B7E2

RefSeq proteins (1): NP_660315* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR029174DUF4637Domain

Pfam: PF15470

UniProt features (5 total): compositionally biased region 2, chain 1, region of interest 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8WW18-F158.440.00

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 21 (showing top): HP1SITEFACTOR_Q6, TGGAAA_NFAT_Q4_01, MIKKELSEN_MEF_ICP_WITH_H3K27ME3, CHYLA_CBFA2T3_TARGETS_UP, PEDRIOLI_MIR31_TARGETS_UP, MIR12128, MIR329_5P, MIR4257, chr17q12, GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN, WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME, GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN, GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP, GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN, GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP

GO Biological Process (0):

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
binding1

Protein interactions and networks

STRING

132 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
C17orf50SPMAP1A8MV24693
C17orf50CFAP97D1B2RV13691
C17orf50SPEM2Q0P670668
C17orf50TBC1D3KA0A087X1G2570
C17orf50KRTAP9-7A8MTY7545
C17orf50CDRT15L2A8MXV6507
C17orf50TBC1D3HP0C7X1475
C17orf50KRTAP9-8Q9BYQ0447
C17orf50TBC1D28Q2M2D7445
C17orf50OR1E2P47887433
C17orf50TBC1D3DA0A087WVF3432
C17orf50SLC35G3Q8N808418
C17orf50SLC35G6P0C7Q6418
C17orf50OR1D5P58170417
C17orf50CCDC144AA2RUR9415

IntAct

34 interactions, top by confidence:

ABTypeScore
C17orf50psi-mi:“MI:0915”(physical association)0.560
C17orf50CIB3psi-mi:“MI:0915”(physical association)0.560
KRT34C17orf50psi-mi:“MI:0915”(physical association)0.560
C17orf50CTNNA3psi-mi:“MI:0915”(physical association)0.560
C17orf50ZNF587psi-mi:“MI:0915”(physical association)0.560
C17orf50PCSK5psi-mi:“MI:0915”(physical association)0.560
KRTAP10-8C17orf50psi-mi:“MI:0915”(physical association)0.560
VWC2LC17orf50psi-mi:“MI:0915”(physical association)0.560
KRTAP10-5C17orf50psi-mi:“MI:0915”(physical association)0.560
ANKS1AC17orf50psi-mi:“MI:0915”(physical association)0.560
C17orf50psi-mi:“MI:0915”(physical association)0.000
KRTAP10-8C17orf50psi-mi:“MI:0915”(physical association)0.000
VWC2LC17orf50psi-mi:“MI:0915”(physical association)0.000
KRTAP10-5C17orf50psi-mi:“MI:0915”(physical association)0.000
ANKS1AC17orf50psi-mi:“MI:0915”(physical association)0.000
CIB3C17orf50psi-mi:“MI:0915”(physical association)0.000
KRT34C17orf50psi-mi:“MI:0915”(physical association)0.000
ZNF587C17orf50psi-mi:“MI:0915”(physical association)0.000
PCSK5C17orf50psi-mi:“MI:0915”(physical association)0.000
CTNNA3C17orf50psi-mi:“MI:0915”(physical association)0.000

BioGRID (12): C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Two-hybrid), C17orf50 (Affinity Capture-MS)

ESM2 similar proteins: A0A1B0GTK4, A0A1B0GTK5, A0JNL8, A2RUT3, A4D250, B2KGE5, F1MQW7, F2Z3F1, F5HHT4, O93195, O95411, P04610, P05905, P0C733, P0C7M3, P0DP71, P16722, P17758, P47939, P47940, P57738, Q0VD86, Q1HVB5, Q1RN00, Q1X6Y7, Q1X6Z1, Q1X6Z2, Q3ZN08, Q5PR19, Q5PXH1, Q5TC04, Q5TEZ4, Q64902, Q66669, Q66HF0, Q67863, Q6DGF6, Q6UYE1, Q7L4S7, Q8AZJ3

Diamond homologs: Q8C1R3, Q8WW18

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

13 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance9
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
2574697GRCh37/hg19 17q11.2-12(chr17:30572862-35843988)Pathogenic

SpliceAI

462 predictions. Top by Δscore:

VariantEffectΔscore
17:35764004:CA:Cacceptor_loss0.9900
17:35764005:A:AGacceptor_gain0.9900
17:35764006:G:GGacceptor_gain0.9900
17:35764006:GGT:Gacceptor_gain0.9900
17:35764006:GGTGT:Gacceptor_gain0.9900
17:35764005:AG:Aacceptor_gain0.9800
17:35764006:GG:Gacceptor_gain0.9800
17:35760950:GCATG:Gdonor_gain0.9700
17:35760951:CATGG:Cdonor_loss0.9700
17:35760955:G:GCdonor_loss0.9700
17:35760956:T:Adonor_loss0.9700
17:35760955:G:GGdonor_gain0.9500
17:35763998:G:Aacceptor_gain0.9500
17:35760953:TG:Tdonor_gain0.9400
17:35760954:GG:Gdonor_gain0.9400
17:35760957:GA:Gdonor_loss0.9400
17:35762764:C:Tdonor_gain0.9300
17:35764005:AGGT:Aacceptor_gain0.9300
17:35764006:GGTG:Gacceptor_gain0.9300
17:35764689:T:TAacceptor_gain0.9200
17:35764691:G:Cacceptor_gain0.9200
17:35760946:A:Gdonor_gain0.9100
17:35760951:CATG:Cdonor_gain0.9100
17:35764161:AGCGG:Adonor_gain0.9100
17:35760945:GA:Gdonor_gain0.9000
17:35764238:T:TAdonor_gain0.8800
17:35764239:G:GAdonor_gain0.8800
17:35760952:ATG:Adonor_gain0.8700
17:35764160:T:TAdonor_gain0.8700
17:35764240:GCGCT:Gdonor_gain0.8700

AlphaMissense

1116 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:35764514:T:CF141L0.978
17:35764516:C:AF141L0.978
17:35764516:C:GF141L0.978
17:35764518:G:AC142Y0.975
17:35764540:C:AH149Q0.971
17:35764540:C:GH149Q0.971
17:35764026:G:CW11C0.969
17:35764026:G:TW11C0.969
17:35764517:T:AC142S0.968
17:35764518:G:CC142S0.968
17:35764579:C:AH162Q0.966
17:35764579:C:GH162Q0.966
17:35764517:T:CC142R0.965
17:35764526:T:AC145S0.965
17:35764527:G:CC145S0.965
17:35764538:C:GH149D0.964
17:35764503:G:AC137Y0.961
17:35764519:C:GC142W0.958
17:35764564:C:AH157Q0.955
17:35764564:C:GH157Q0.955
17:35764526:T:CC145R0.954
17:35764502:T:AC137S0.947
17:35764503:G:CC137S0.947
17:35764569:T:AV159D0.947
17:35764452:G:AC120Y0.944
17:35764518:G:TC142F0.943
17:35764451:T:AC120S0.942
17:35764452:G:CC120S0.942
17:35764515:T:CF141S0.941
17:35764024:T:AW11R0.938

dbSNP variants (sampled 300 via entrez): RS1002296935 (17:35759657 C>T), RS1002347829 (17:35759820 C>T), RS1002981605 (17:35764357 G>A), RS1004296619 (17:35759886 T>A), RS1004753345 (17:35760144 T>A,C), RS1005463380 (17:35763272 A>C), RS1007148891 (17:35761852 C>T), RS1007481056 (17:35760263 C>T), RS1008534228 (17:35759382 G>A), RS1009453032 (17:35765030 C>A), RS1010891691 (17:35765162 C>A,T), RS1011228620 (17:35764017 C>G,T), RS1011504374 (17:35759441 C>A), RS1013386313 (17:35761770 C>A,G), RS1013468710 (17:35763162 G>A)

Disease associations

OMIM: gene `` | disease phenotypes: MIM:614527

GenCC curated gene-disease

Mondo (1): chromosome 17q12 deletion syndrome (MONDO:0013797)

Orphanet (1): 17q12 microdeletion syndrome (Orphanet:261265)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST007001_12Cerebrospinal AB1-42 levels in normal cognition4.000000e-07

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0004670beta-amyloid 1-42 measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

2 total (human), top 2 by PubMed support.

ChemicalActions (top 5)PubMed papers
Arsenicaffects methylation1
Valproic Acidincreases methylation1

Clinical trials (associated diseases)

1 trials via MONDO — disease-level, not drug-specific.

TrialPhaseStatusTitle
NCT01238250Not specifiedRECRUITINGOnline Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): chromosome 17q12 deletion syndrome